Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 34 Carcinoma, Intraductal, Noninfiltrating 3 Breast Diseases 3 Neoplasms by Site 2 Neoplasms 2 Neoplasm Metastasis 2 Breast Neoplasms, Male 2 Advanced Breast Cancer 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sexual Dysfunctions, Psychological 1 Ovarian Neoplasms 1 Low Grade Serous Ovarian Cancer 1 Locoregional Recurrence 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 HER2 Negative Breast Cancer 1 Endometrial Neoplasms 1 Breast Neoplasm Female 1 Breast Carcinoma In Situ 1 Anatomic Stage III Breast Cancer AJCC v8 1 Anatomic Stage II Breast Cancer AJCC v8 1 Advanced Breast Carcinoma 1

Interventions

ribociclib 1 Letrozole 1 Goserelin 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Negative Breast Cancer × Anastrozole × 90 days × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡